Vivien E. Prise
Impact in
- Cancer Research top 5%
- Cancer, Hypoxia, and Metabolism
- Molecular Biology top 10%
- Angiogenesis and VEGF in Cancer
Papers in
-
- Cancer, Hypoxia, and Metabolism 15
- Physiology 13
- Nitric Oxide and Endothelin Effects 13
- Co-authors
- G. M. TozerGillian M. TozerD J ChaplinS A HillJohn WilsonBorivoj VojnovicGeorge R. PettitG. Dark
- Journals
- International Journal of Cancer (6 papers)British Journal of Cancer (3 papers)Advances in experimental medicine and biology (2 papers)Acta Oncologica (2 papers)Cancer Research (1 paper)
- Partner nations
- United KingdomUnited StatesSlovakia
In The Last Decade
Vivien E. Prise
33 papers receiving 1.8k citations
Hit Papers
Peers
Comparison fields: 5 of 103
- Cancer Research 576
- Molecular Biology 1.1k
- Oncology 401
- Radiology, Nuclear Medicine and Imaging 270
- Organic Chemistry 313
Countries citing papers authored by Vivien E. Prise
This map shows the geographic impact of Vivien E. Prise's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Vivien E. Prise with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Vivien E. Prise more than expected).
Fields of papers citing papers by Vivien E. Prise
This network shows the impact of papers produced by Vivien E. Prise. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Vivien E. Prise. The network helps show where Vivien E. Prise may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Vivien E. Prise, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2021 | 15 | |
| 2 | 2016 | 1 | |
| 3 | Lp-PLA 2 is a potential therapeutic target in diabetic macula edema | 2013 | 2 |
| 4 | 2008 | 83 | |
| 5 | 2008 | 67 | |
| 6 | 2008 | 42 | |
| 7 | 2005 | 10 | |
| 8 | 2002 | 88 | |
| 9 | 1999 | 9 | |
| 10 | 1998 | 21 | |
| 11 | 1997 | 8 | |
| 12 | 1996 | 2 | |
| 13 | 1996 | 7 | |
| 14 | 1995 | 76 | |
| 15 | 1995 | 10 | |
| 16 | 1995 | 16 | |
| 17 | 1994 | 0 | |
| 18 | 1994 | 23 | |
| 19 | 1994 | 1 | |
| 20 | 1991 | 21 |
About Vivien E. Prise
Vivien E. Prise is a scholar working on Cancer Research, Physiology, Biochemistry, Biophysics and Molecular Biology, having authored 34 papers that have together received 1.9k indexed citations. Recurring topics across this work include Cancer, Hypoxia, and Metabolism (15 papers), Nitric Oxide and Endothelin Effects (13 papers), Angiogenesis and VEGF in Cancer (13 papers), MRI in cancer diagnosis (4 papers), Ultrasound and Hyperthermia Applications (3 papers), Eicosanoids and Hypertension Pharmacology (3 papers), Hemoglobin structure and function (3 papers) and Receptor Mechanisms and Signaling (3 papers). The work is most often cited by research in Cancer Research (576 citations), Molecular Biology (1.1k citations), Oncology (401 citations), Radiology, Nuclear Medicine and Imaging (270 citations) and Organic Chemistry (313 citations). Vivien E. Prise has collaborated with scholars based in United Kingdom, United States and Slovakia. Frequent co-authors include G. M. Tozer, Gillian M. Tozer, D J Chaplin, S A Hill, John Wilson, Borivoj Vojnovic, George R. Pettit, G. Dark, David J. Chaplin and Paul R. Barber. Their work appears in journals such as International Journal of Cancer, British Journal of Cancer, Advances in experimental medicine and biology, Acta Oncologica and Cancer Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.